ERBB2 and breast cancer: Since lysis of the non-malignant cell lines SVGA and hCMEC/D3 was similar to that of MDA-MB-231 and MCF-7 breast cancer cells with comparable HER2 expression, we investigated whether other factors, such as HLA-I expression, may still modulate HER2-directed CAR NK-92 cell activity.